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ABSTRACT 
   
     Acute meningitis in children is predominantly aseptic and does not require specific treatment. However, 
meningitis has a bacterial origin in about 5% of patients and carries a risk of fatal outcome or severe 
neurological sequelae, especially when diagnosis and antibiotic administration are delayed. The objective of 
the present study was to evaluate the value of determining procalcitonin levels to discriminate between 
bacterial and non-bacterial meningitis in young children or infants and describe the variation in serum PCT 
levels over time during the treatment of meningitis. 
A total of 50 children with meningitis admitted to a University Hospital were followed in this prospective 
study. Cerebrospinal fluid (CSF) and serum levels of procalcitonin were measured. The diagnosis of 
meningitis was based on clinical findings, gram staining, culture, and chemical analysis of CSF. Twenty-five 
children were diagnosed as bacterial meningitis and the other 25 children as non-bacterial Meningitis.  
The mean procalcitonin level on admission in patients with acute bacterial meningitis was 18.3 ng/mL, and 
the lower level was 4.6 ng/mL, while the higher level in patients with non-bacterial meningitis was 0.62 
ng/mL (mean level, 0.38 ng/mL). It  is  clear  from  the  range  of  serum procalcitonin level that, there are 
no overlapping values seen  for  serum  procalcitonin  in  both  groups. 
serum PCT levels can be used in the early diagnosis of acute bacterial meningitis and is more valuable than 
the other predictive marker. Similarly, they may be useful adjuncts in differential diagnosis of bacterial and 
non-bacterial meningitis and diminishing the value of 2
nd
 lumbar puncture performed 48-72 hours after 
admission to assess treatment efficacy. 
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INTRODUCTION  
     Acute meningitis in children is predominantly 
aseptic and does not require specific treatment. 
However, meningitis has a bacterial origin in about 
5% of patients [1-3] and carries a risk of fatal 
outcome or severe neurological sequelae, 
especially when diagnosis and antibiotic 
administration are delayed [4, 5]. Because 
distinguishing between bacterial and non-bacterial 
meningitis in the emergency department (ED) is 
some-times difficult, many recommend that 
antibiotic treatment be started immediately in 
children on clinical evidence of acute meningitis 
and/or cerebrospinal fluid (CSF) pleocytosis and 
that treatment be continued until bacterial culture 
results become available 48 to 72 hours later [6, 7]. 
These recommendations assure rapid treatment of 
children with bacterial meningitis but result in 
systematic hospitalization and antibiotic 
administration for children with non-bacterial 
meningitis, with the morbidity and economic 
burden that accompany them [8-10]. Therefore, 
distinguishing between bacterial and non-bacterial 
meningitis in the ED could help to limit 
unnecessary antibiotic use and hospital admissions. 
Because the consequences of delayed diagnosis of 
 




bacterial meningitis can be severe, any proposed 
diagnostic tool must achieve near 100% 
sensitivity[11]. In untreated bacterial meningitis, 
Gram staining of CSF reveals bacteria in about 50-
80% of cases and cultures are positive in at least 
85% of cases. However, sensitivity of both tests is 
less than 50% in patients who are already on 
antibiotic treatment. Also, Clinical criteria [12-14] 
and bacterial antigen testing of CSF as well as the 
classic biological markers in blood (C-reactive 
protein [CRP] level, white blood cell [WBC] 
count, and neutrophil count) or CSF (protein level, 
glucose level, WBC count, and neutrophil count) 
[2,5,7,15] used alone do not offer 100% sensitivity 
with high specificity for distinguishing between 
bacterial and non-bacterial meningitis. Among new 
markers, serum procalcitonin (PCT) level [16] 
seems to be one of the most sensitive and specific 
predictors for discriminating between bacterial and 
non-bacterial infections [17, 18].   
Procalcitonin (PCT), which is a calcitonin 
propeptide, is supposed to be synthesized in C cells 
of the thyroid gland [19] and secreted from 
leukocytes of the peripheral blood. The secretion of 
PCT was found to increase in the presence of 
bacterial lipopolysaccharides and cytokines that are 
associated with sepsis [16, 20]. It was previously 
shown that serum PCT levels increase during the 
course of bacterial, parasitic or fungal infections, 
but remain normal or slightly increase in viral 
infections and inflammatory reactions that are not 
infectious [21, 22]. The objective of the present 
study was to evaluate the value of determining 
procalcitonin levels to discriminate between 
bacterial and non-bacterial meningitis in young 
children or infants and describe the variation in 
serum PCT levels over time during the treatment of 
meningitis. 
 
MATERIALS AND METHODS  
     A total of 50 children with meningitis admitted 
to a University Hospital were followed in this 
prospective study. Twenty-five children were 
diagnosed as bacterial meningitis and the other 25 
children as non-bacterial Meningitis. Informed 
signed consent was obtained from parents for their 
children to participate in the study. Meningitis was 
diagnosed according to evaluation of history, 
physical examination, CSF laboratory findings, 
identification of bacterial agents in CSF Gram 
staining and cultures. Meningitis is defined as 
bacterial if the CSF laboratory findings (increased 
protein >2 g/l, decreased glucose ratio <0.4, and 
leukocyte count >1500 /µl and polymorph nuclear 
leukocyte domination), identification of bacterial 
agents in Gram staining and/or bacterial culture 
were positive; or was defined as non-bacterial 
meningitis if the acute onset of meningitis and the 
absence of any bacterial meningitis criteria. Blood 
serum samples were taken from all cases at the 
time of diagnosis and at 48-72 h of treatment. The 
blood glucose level, peripheral leukocyte count, 
erythrocyte sedimentation rate, qualitative CRP 
and serum PCT in blood serum samples and the 
protein, glucose and number and type of cells in 
CSF samples were simultaneously investigated. 
Symptoms and findings at the time of diagnosis, 
demographical data, peripheral leukocyte count, 
erythrocyte sedimentation rate, and follow-up body 
temperature (body temperature >37.8 ̊ C, armpit) 
of cases were monitored.  
EDTA was added to blood samples obtained by 
venipuncture. Procalcitonin levels were measured 
in frozen samples (temperature, -20 ̊ C) in a blind 
manner by immunoluminometric assay (BRAHMS 
Diagnostica, Berlin). This assay, which is specific 
for the procalcitonin molecule, requires 20 µL of 
plasma and can be done within 2 hours. Its 
detection limit is 0.1 µg/L. Interassay and 
intraassay variations at both low and high 
concentrations are <8% and <7%, respectively. 
Plasma procalcitonin levels in healthy children or 
adults, as determined with this assay, are <0.1 
ng/mL. We measured levels of serum C-reactive 
protein (CRP) and CSF proteins and CSF cell 
counts by routine methods. Statistical analysis of 
data was carried out in a windows setting using the 
SPSS 16.0 program. Differences between groups in 
continuous variables were tested for significance 
with the Mann-Whitney test. Two-tailed p≤0.05 
was considered significant. 
 
RESULTS 
    Of the 50 cases with meningitis, 32 (64%) were 
males and 18 (36%) were females. The mean age 
was 59.16±30.7 months and the age range was 4-
158 months. (Table 1). There was no difference 
between bacterial and non-bacterial meningitis 
groups in respect to mean age (p >0.05). Clinical 
characteristics and laboratory findings in both 
 




groups are summarized in Table 1. The most 
common symptoms at the time of diagnosis in all 
study groups were fever (100%), nausea or 
vomiting (48%), Headache (42%) and convulsion 
(38%). The mean values and ranges for CSF 
leukocyte counts, CSF protein levels, glucose 
levels, and procalcitonin levels in both groups are 
shown in table 2. The differences in the mean 
values were highly statistically significant for any 
of the four tests. Bacterial culture revealed 
Neisseria meningitidis in 11 cases, Haemophilus 
influenza in 6 cases, Streptococcus pneumoniae in 
5 cases, Escherichia coli in 2 case, and 
Pseudomonas aeuroginosae in one case. 
The mean procalcitonin level on admission in 
patients with acute bacterial meningitis was 18.3 
ng/mL, and the lower level was 4.6 ng/mL, while 
the higher level in patients with non-bacterial 
meningitis was 0.62 ng/mL (mean level, 0.38 
ng/mL). With a procalcitonin level of > 0.5 ng/mL 
as positive cut-off value, the sensitivity for 
diagnosis of bacterial meningitis was 100%, and 
the specificity was 96%, positive predictive value 
of 96% and negative predictive value of 100%. It  
is  clear  from  the  range  of  serum procalcitonin 
level that, there are no overlapping values seen  for  
serum  procalcitonin  in  both  groups. 
Twenty-one patients with non-bacterial meningitis 
received an antibiotic as presumptive treatment for 
bacterial meningitis until the viral origin was 
determined. Six patients had pleocytosis (cell 
count, >1,000/ µL). Initial procalcitonin levels 
ranged from 0.08 ng/mL to 0.62 ng/mL among 
these 21 treated children and were similar to the 
levels for other patients with non-bacterial 
meningitis who were not treated. Procalcitonin 
levels were measured during treatment in all 
patients with bacterial meningitis. In all cases, a 
marked decrease was observed after 72 hours. All 
patients had procalcitonin levels of <1 ng/mL at 
recovery (Figure 1).  
Procalcitonin levels were measured in nine patients 
with non-bacterial meningitis on the second and 
third days. These levels always remained <1 
ng/mL. Procalcitonin levels in blood and CSF 
samples collected at the same time were 
determined for all patients with bacterial 
meningitis and 16 patients with non-bacterial 
meningitis. No procalcitonin was found in the CSF 
samples.  
 
Table 1. Clinical and demographic features of all groups 
Parameters Bacterial meningitis non-bacterial meningitis 
Gender (%) 
Male 15 (60) 17 (68) 
Female 10 (40) 8 (32) 
Clinical feature (%) 
Fever 25 (100) 25 (100) 
Nausea or vomiting 10 (40) 14 (56) 
Headache 12 (48) 9 (36)  
Convulsion 10 (40) 9 (36) 
Parotitis 0 (0.0) 7 (28) 
Laboratory findings 
Erytrocyte sedimentation rate (mm/h) 31.2 ± 22.8 18.4 ± 9.5 
Leukocyte count (/µL) 15000 ± 2900 9500 ±1105 
 
Table 2. CSF leukocyte counts, CSF protein levels, glucose levels, and procalcitonin levels in both groups 



















1460 ± 970  
(350 - 1750) 
2.2 ± 1.15 
(0.35 - 3.7) 
0.31 ± 0.21 
(0.11 - 0.47) 
18.3 ± 7.85 
(4.6 - 34.1) 
1371± 745 
(268 -1330) 




410 ± 312  
(215 - 1050) 
0.61± 0.45 
(0.1 - 0.97) 
0.58 ± 0.23 
(0.45 - 0.83) 
0.38 ±0.25  
(0.01 – 0.62) 
96 ± 140 
(11 – 120) 
395 ±230 
(200 – 980) 
P-value <0.001 <0.001 <0.01 <0.001 <0.001 <0.01 
 






Figure 1. change in serum procalcitonin from admission to day 3 of treatment in bacterial meningitis group 
 
DISSCUSION 
     A good biomarker for Bacterial infection 
should fulfill the following criteria; early 
diagnostic, prognostic value and helpful for 
therapeutic antimicrobial decisions [23, 24]. In the 
last few years, serum PCT level has been reported 
to be useful in the establishment of severe 
bacterial infections and in the follow up of 
treatment. In comparison to other commonly used 
tests, Procalcitonin appears to be a more specific 
and sensitive marker of a variety of infections, 
e.g. respiratory tract infections, meningitis, acute 
infectious endocarditis and pancreatitis. The role 
of PCT has also been extensively studied in the 
intensive care setting; here it is important that an 
accurate distinction made between inflammatory 
states and viral and bacterial infection [25, 26, 
27]. To date, there have been only a few reports in 
the literature on serum PCT as a marker in the 
differential diagnosis of meningitis in childhood. 
In these studies, serum PCT was shown to be 
sensitive and specific with a range of 69-100% 
[28]. In the study reported by Schwarz et al [28], 
sensitivity of PCT was lower (69%). In our study, 
in confirm of previously studies, the sensitivity 
for diagnosis of bacterial meningitis was 100%, 
and the specificity was 96%. 
In this study we found that serum procalcitonin 
levels were exclusively high in patients with 
bacterial culture positive meningitis, prior to 
treatment and became very low during follow up 
with treatment. Moreover, if we look at the PCT 
value, it is highly discriminate in all cases. The 
mean PCT level in patients with bacterial 
meningitis was 18.3 ng/ml, and the lower level 
was 4.6 ng/ml, while the higher PCT level in 
patients with non bacterial meningitis was 0.62 
ng/ml and the mean was 0.38 ng/ml. It means that, 
the highest value of procalcitonin seen in patients 
with non bacterial meningitis is still lower than 
the lower value of PCT seen in patients with 
bacterial meningitis. This result is in agreement 
with that obtained by many researchers. They 
found that PCT concentration increased in 
bacterial meningitis with or without shock, but 
remained low in viral meningitis and 
inflammatory diseases [24, 29, 30].  
An explanation for increased PCT levels in 
bacterial meningitis was a global increase of the 
first calcitonin gene (CALC I gene) expression 
and a cardinal release of PCT from all 
parenchymal tissues and differentiated cell types 
throughout the body induced by a microbial 
infection [31]. The largest tissue mass and major 
source of circulating PCT in sepsis is provided by 
Parenchymal cells (including liver, lung, kidney, 
adipocytes and muscle) and not the leukocyte 
population. The high serum PCT levels are seen 
in septic patients after near complete eradication 
of these leukocyte cells by antimicrobial therapy 
[32]. 
Procalcitonin levels measured at 48-72 h of the 
treatment were found to be less than the level 
measured at the beginning of treatment, but did 
not return to normal values as the healthy subjects 
at 48 h. This finding suggests that the serum PCT 
level continues to be high for 48 h (despite 
treatment) and can be used for diagnosis for at 
least 48 h. Nevertheless, it is more reliable in 
diagnosis when measured before starting any 
treatment. Normally, PCT is very low in 
circulation or in serum of healthy subjects as well 
as in patients with inflammatory diseases, reaches 
high concentrations in patients with severe 
bacterial infection and decreases rapidly after 
appropriate antibiotic therapy [33]. 
 




In this study, in accordance with the literature, 
gram staining of CSF was positive in only 52% of 
the bacterial meningitis cases, and culture was 
positive in 92%. For example, Marton and Gean 
(34) have shown that culture was positive in 60% –
90% of acute bacterial meningitis cases and fell to 
40% – 60% in patients who had previous antibiotic 
therapy [35]. In bacterial meningitis, the CSF 
WBC count usually ranges between 1000 and 
5000/µL, with a neutrophilic predominance, 
but‚10% of the patients with bacterial meningitis 
had a lymphocytic predominance [35], as in our 
study. 
The estimation of the sensitivity and the specificity 
of CSF protein levels and ratio of glucose in CSF 
to glucose in serum in bacterial meningitis vary 
according to the study. In the diagnosis of acute 
bacterial meningitis, it was found that a CSF 
protein level >1 g/L gives a sensitivity and 
specificity of 82% and 98%, respectively [36], or a 
CSF protein level >2 g/L gives a sensitivity and 
specificity of 86% and 100%, respectively [37].  
Similar results were found in this study. The ratio 
of glucose in CSF to glucose in serum is widely 
used; in diagnosis of bacterial meningitis, a 
value›<0.4 yielded a sensitivity and specificity of 
80% – 91% and 96% – 98%, respectively [35, 36]. 
In conclusion, serum PCT levels can be used in the 
early diagnosis of acute bacterial meningitis and is 
more valuable than the other predictive marker. 
Similarly, they may be useful adjuncts in 
differential diagnosis of bacterial and non bacterial 
meningitis and diminishing the value of 2
nd
 lumbar 
puncture performed 48-72 hours after admission to 
assess treatment efficacy. 
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